Pediatrix Medical Group, Inc. (NYSE:MD) Receives Average Rating of “Hold” from Analysts

Pediatrix Medical Group, Inc. (NYSE:MD) has earned an average recommendation of “Hold” from the six analysts that are currently covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $22.50.

Several analysts recently issued reports on MD shares. Truist Financial upped their price objective on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the stock a “hold” rating in a report on Monday, April 13th. UBS Group upped their price objective on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Tuesday, May 12th. Mizuho set a $24.00 price objective on shares of Pediatrix Medical Group in a report on Friday, May 8th. Deutsche Bank Aktiengesellschaft set a $19.00 price objective on shares of Pediatrix Medical Group in a report on Friday, February 20th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $27.00 price objective on shares of Pediatrix Medical Group in a report on Monday, April 20th.

Pediatrix Medical Group Price Performance

NYSE MD opened at $24.19 on Wednesday. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.45. The company has a fifty day simple moving average of $22.55 and a 200 day simple moving average of $21.71. The company has a market cap of $1.99 billion, a P/E ratio of 11.74 and a beta of 0.69. Pediatrix Medical Group has a 1 year low of $11.84 and a 1 year high of $24.99.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.07. The business had revenue of $476.20 million during the quarter, compared to the consensus estimate of $465.83 million. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. Pediatrix Medical Group’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.33 EPS. On average, sell-side analysts predict that Pediatrix Medical Group will post 2.1 EPS for the current year.

Insider Buying and Selling

In other news, Director Shirley A. Weis sold 36,028 shares of the stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total value of $855,665.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 1.80% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Pediatrix Medical Group

A number of hedge funds have recently made changes to their positions in MD. Keybank National Association OH grew its holdings in Pediatrix Medical Group by 2.0% during the 1st quarter. Keybank National Association OH now owns 22,941 shares of the company’s stock worth $491,000 after acquiring an additional 458 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in Pediatrix Medical Group by 4.5% during the 3rd quarter. PNC Financial Services Group Inc. now owns 14,525 shares of the company’s stock worth $243,000 after acquiring an additional 631 shares during the last quarter. Gotham Asset Management LLC grew its holdings in Pediatrix Medical Group by 0.6% during the 3rd quarter. Gotham Asset Management LLC now owns 116,093 shares of the company’s stock worth $1,945,000 after acquiring an additional 724 shares during the last quarter. ProShare Advisors LLC grew its holdings in Pediatrix Medical Group by 4.6% during the 4th quarter. ProShare Advisors LLC now owns 16,816 shares of the company’s stock worth $360,000 after acquiring an additional 734 shares during the last quarter. Finally, Verition Fund Management LLC boosted its stake in shares of Pediatrix Medical Group by 4.4% in the 3rd quarter. Verition Fund Management LLC now owns 25,408 shares of the company’s stock valued at $426,000 after purchasing an additional 1,066 shares during the last quarter. Institutional investors and hedge funds own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.